| 摘要 |
<p>Hybrid or fusion peptides formed by the fusion of two or more peptide components, where one component is derived from or is all or part of a malaria parasite red blood cell binding peptide, and the other peptide being a receptor for or capable of binding to a cytokine or other mediator of inflammation or immunity. The fusion peptides find a use in the treatment of septic shock, AIDS, and inflammatory conditions. The fusion peptides also serve as potential testing agents for use in inflammatory conditions and septic shock.</p> |
